Abbott Libre Rio
Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin.
Keep in mind FDA clearance is not proof of released sales. Lingo and Libre-family specifications are not substituted.
Compare wearables
Compare up to 10 devices across categories. Keep the purpose and the source beside the numbers.
How price order works
Lowest recorded store prices take priority over announced or launch prices, within the selected source market. Currencies use the dated EUR reference rates. Deposits and recurring charges are excluded from price order; missing prices stay last. Original price records remain visible.
At a glance
The differences that matter
Dexcom Stelo
Over-the-counter upper-arm glucose biosensor shows trends for adults not on insulin.
Keep in mind Do not use for problematic hypoglycemia. Medical decisions require consultation with a qualified professional.
Published specifications and documented constraints. See the full comparison below for prices and sources.
Scroll across the table to compare every model
| Biosensors & healthAdd a model |  |  |
|---|---|---|
| Prices · all markets | Price not verified 0 offer records & sourcesNo verified price in this audit. | $99 USD≈ €89 EURECB 2026-10-12US · Store price · Listed 1 offer records & sources$99 USD≈ €89 EURECB 2026-10-12 US · Store price ListedDexcom One-time purchase, two biosensors Official displayed price; shipping destination, tax treatment and checkout not tested.Check merchant offer ↗Price source ↗ Checked 2026-10-12 |
| Designed for | Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin. ↗ | Over-the-counter upper-arm glucose biosensor shows trends for adults not on insulin. ↗ |
| Form factor | Continuous glucose biosensor ↗ | Upper-arm CGM biosensor ↗ |
| Measurement | Interstitial glucose monitoring ↗ | Continuous interstitial glucose ↗ |
| Intended Users | Adults 18+ with type 2 diabetes, not using insulin ↗ | Adults 18+ not on insulin, without problematic hypoglycemia ↗ |
| USRegulatory | FDA OTC iCGM clearance announced June 2024 ↗ | Not applicable to this category |
| Interface | CGM system for glucose-pattern review ↗ | Stelo app for compatible smartphones ↗ |
| Wear Duration | Not verified | Up to 15 days ↗ |
| Vision correction | Not applicable to this category | No prescription required in the US ↗ |
| Purpose Class | Not applicable to this category | OTC integrated continuous glucose monitor ↗ |
| Availability | Official 2024 clearance announcement confirmed; no current exact Libre Rio retail launch or price verified. | Official product documentation checked. Country-specific fulfilment and checkout were not tested. |
| Important context |
|
|
| Editorial pick & release | No editorial ranking recorded | No editorial ranking recorded |
| Evidence | Manufacturer source Checked 2026-10-13 | Manufacturer source Checked 2026-10-12 |
Battery claims use different conditions and are not a controlled benchmark. “Not verified” is an evidence gap, not a missing feature. Prices are dated regional snapshots. Deposits, bundles and historical launch prices are labelled. Brightness measurement methods and battery workloads vary by manufacturer.